Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
An essential component of risk-based quality management (RBQM), as detailed in both the ICH E8 (R1)...
Source: Applied Clinical Trials
- Press Release
CluePoints Appoints Richard Young as Chief Strategy Officer King of Prussia, PA – October 28th, 2024:...
- Press Release
King of Prussia, PA – October 23rd, 2024: CluePoints, provider of leading statistical and AI-driven software...
- Featured Article
The need to boost education, shift culture, and embrace new technologies.
...Source: Applied Clinical Trials
- Press Release
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest...
- Featured Article
As an industry, we regularly discuss the benefits of adopting risk-based quality management (RBQM). The good...
Source: International Clinical Trials/European Pharmaceutical Contractors
- Featured Article
François Torche dispels the myth that, at least in RBQM, there is such a thing as...
Source: PM360
- Featured Article
An increase in clinical trial data is driving demand for enhanced clinical trial processes. Sponsors want...
Source: Journal for Clinical Studies
- Featured Article
Artificial intelligence (AI) is a hot topic in pharma with myriad uses such as supporting clinical...
Source: Outsourcing Pharma
- Featured Article
With increasing pressure to overcome drug development challenges and advance drugs to market faster and with...
Source: Contract Pharma
- Featured Article
Today’s drug development landscape demands contract research organizations (CROs) provide flexible models that leverage the latest...
Source: Contract Pharma
- Featured Article
In an interview with ACT editor Andy Studna at DIA 2024, Hughes, co-founder and chief commercial...
Source: Applied Clinical Trials
- Press Release
CluePoints, the premier provider of Risk-Based Quality Management software for clinical trials, has partnered with ZS,...
- Press Release
For well over a year now, the clinical research community has been hard at work to...
- Press Release
Risk-Based Monitoring is the future of clinical trials – but despite significant advances in recent years,...
- Press Release
Have you heard the news? CluePoints is sponsoring RBQM Live on behalf of the industry! The...
- Press Release
In the world of clinical trials, if it isn’t documented, it didn’t happen. It’s a philosophy...
- Press Release
It has never been more important for the clinical trial community to come together and share...
- Press Release
King of Prussia, PA – January 19, 2021: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – December 8th, 2020: CluePoints, the premier provider of Central Statistical Monitoring,...
- Press Release
LOUVAIN-LA-NEUVE, BELGIUM; KING OF PRUSSIA, PA; and LONDON, UK (September 1, 2020) – CluePoints S.A., a...
- Press Release
Addressing COVID-19 Specific Regulatory Guidance and Ensuring Early Risk Detection King of Prussia, PA: CluePoints, the...
- Press Release
On July 28, CluePoints is teaming up with DIA for a webinar to explore how the...
- Press Release
Personalizing the Power of Statistical Analysis and Data Visualization King of Prussia, PA: CluePoints, the premier...
- Featured Article
Risk-based quality management (RBQM) is used to identify and assess risks then finding ways to manage...
Source: OutsourcingPharma
- Featured Article
The ICH E6(R3) draft guideline document, currently open to public consultation, places the industry firmly in...
Source: Applied Clinical Trials
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Featured Article
CluePoints is continuing to invest in artificial intelligence (AI) and machine learning (ML) they say they...
Source: Outsourcing Pharma
- Featured Article
With the clinical trial landscape continuing to evolve and adapt, OSP took the opportunity to speak...
Source: Outsourcing Pharma
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
